Mitochondrial disease: when the powerhouse goes awry.
暂无分享,去创建一个
[1] Marni J. Falk,et al. A modern approach to the treatment of mitochondrial disease , 2009, Current treatment options in neurology.
[2] Y. Li,et al. Mitochondrial Gene Replacement in Primate Offspring and Embryonic Stem Cells , 2009, Nature.
[3] D. Wallace,et al. The pathophysiology of mitochondrial disease as modeled in the mouse. , 2009, Genes & development.
[4] S. Jou,et al. Mitochondrial dysfunction and psychiatric disorders. , 2009, Chang Gung medical journal.
[5] Ferdinando Palmieri,et al. Diseases caused by defects of mitochondrial carriers: a review. , 2008, Biochimica et biophysica acta.
[6] Robert W. Taylor,et al. Prevalence of mitochondrial DNA disease in adults , 2008, Annals of neurology.
[7] K. Sobue,et al. Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy , 2007, Journal of Anesthesia.
[8] A. M. Salio,et al. Coenzyme Q 10 Improves Lactic Acidosis, Strokelike Episodes, and Epilepsy in a Patient With MELAS (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike episodes) , 2004, Clinical neuropharmacology.
[9] B. Cohen,et al. Treatment of Mitochondrial Cytopathies , 2001, Seminars in neurology.
[10] M. Tarnopolsky,et al. Creatine monohydrate increases strength in patients with neuromuscular disease , 1999, Neurology.
[11] H. Reichmann,et al. Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy , 1998, Journal of Neurology.
[12] P. Matthews,et al. Effects of aerobic training in patients with mitochondrial myopathies , 1998, Neurology.
[13] M. Tarnopolsky,et al. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies , 1997, Muscle & nerve.
[14] J. Arenas,et al. Plasma carnitine insufficiency and effectiveness of L‐carnitine therapy in patients with mitochondril myopathy , 1993, Muscle & nerve.
[15] Y. Mashima,et al. Remission of Leber's hereditary optic neuropathy with idebenone , 1992, The Lancet.
[16] N. Nishitani,et al. Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke‐like episodes (MELAS) , 1991, Acta neurologica Scandinavica.
[17] N. Bresolin,et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial , 1990, Journal of the Neurological Sciences.
[18] S. Kuroda,et al. Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone , 1989, Journal of the Neurological Sciences.
[19] U. Muscatello,et al. Changes in mitochondrial activity caused by ammonium salts and the protective effect of carnitine. , 1989, Biochemical and biophysical research communications.
[20] Richard P. Lewis,et al. ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices , 2016 .
[21] N. Chu,et al. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. , 1997, European neurology.
[22] G. Danta,et al. Chronic progressive external ophthalmoplegia. , 1975, Brain : a journal of neurology.